Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
RESEARCH LETTER
Integrated Mendelian randomization and single cell RNA sequencing identify cholesterol gene ABCA1 as a risk factor in oral lichen planus
1
Department of Orthodontics, Hospital of Stomatology, Jilin University, Changchun, China
2
Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Changchun, China
3
Shanghai Pudong New Area People’s Hospital, Shanghai, China
Submission date: 2025-04-07
Final revision date: 2025-10-15
Acceptance date: 2025-10-17
Online publication date: 2025-12-18
Corresponding author
Min Hu
Department of Orthodontics Hospital of Stomatology Jilin University Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling Changchun, China
Department of Orthodontics Hospital of Stomatology Jilin University Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling Changchun, China
TOPICS
REFERENCES (18)
1.
Vinay K, Kumar S, Dev A, et al. Oral acitretin plus topical triamcinolone vs topical triamcinolone monotherapy in patients with symptomatic oral lichen planus. JAMA Dermatol 2024; 160: 80-7.
2.
Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev 2020; 2020: CD001168.
3.
Sun Y, Chen D, Deng X, et al. Prevalence of oral lichen planus in patients with diabetes mellitus: a cross‐sectional study. Oral Dis 2024; 30: 528-36.
4.
Stasio DD, Lucchese A, Romano A, Adinolfi LE, Serpico R, Marrone A. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: a cohort study. Clin Oral Investig 2022; 26: 5409-17.
5.
Shirasuna K. Oral lichen planus: malignant potential and diagnosis. Oral Sci Int 2014; 11: 1-7.
6.
Qing M, Yang D, Shang Q, et al. CD8+ tissue-resident memory T cells induce oral lichen planus erosion via cytokine network. eLife 2023; 12: e83981.
7.
Li Q, Wang F, Shi Y, et al. Single-cell immune profiling reveals immune responses in oral lichen planus. Front Immunol 2023; 14: 1182732.
8.
Zhang Q, Zhao R, Shen X, Sun K. Potential different immune phenotypes of macrophages in oral lichen planus by integrating immunofluorescence double staining and single-cell RNA sequencing. J Dent Sci 2024; 19: 2210-7.
9.
Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22.
10.
Oreamuno YVB, Abarca FM. Difficulties in the treatment of oral lichen planus in a systemically compromised patient: case report and review of the literature. Odovtos Int J Dent Sci 2021: 167-76.
11.
Wongpakorn P, Chantarangsu S, Prapinjumrune C. Factors involved in the remission of oral lichen planus treated with topical corticosteroids. BDJ Open 2024; 10: 34.
12.
Banach M, Surma S, Bielecka-Dąbrowa A, et al. Rosuvastatin-based combination treatment with acetylsalicylic acid or ezetimibe in the management of patients at high and very high cardiovascular risk. Expert opinion paper of the Polish Lipid Association 2025. Arch Méd Sci 2025; 21: 1-15.
13.
Banach M, Surma S, Kapłon-Cieślicka A, et al. Position paper of the Polish Expert Group on the use of pitavastatin in the treatment of lipid disorders in Poland endorsed by the Polish Lipid Association. Arch Méd Sci 2023; 20: 28-42.
14.
Tsui L, Chen L, Ye P, et al. Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis. BMJ Open 2023; 13: e068915.
15.
Forouzan P, Riahi RR, Cohen PR. Atorvastatin-induced lichenoid drug eruption: a case report and review of statin-associated cutaneous adverse events. Cureus 2020; 12: e7155.
16.
Toader MP, Taranu T, Constantin MM, et al. High serum level of interleukin-6 is linked with dyslipidemia in oral lichen planus. Exp Ther Med 2021; 22: 987.
17.
di Calabria VR, Verdelli A, Quintarelli L, et al. Case Report: resolution of lichen planus pemphigoides as an unexpected outcome of SARS-CoV-2 infection. Front Immunol 2023; 14: 1222459.
18.
Ozbagcivan O, Akarsu S, Semiz F, Fetil E. Comparison of serum lipid parameters between patients with classic cutaneous lichen planus and oral lichen planus. Clin Oral Investig 2020; 24: 719-25.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
